During the past decade, Ophthalmic Consultants of Long Island conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 5 clinical trials were completed, i.e. on average, 71.4% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 3 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Ophthalmic Consultants of Long Island" #1 sponsor was "Carolina Eyecare Physicians, LLC" with 2 trials, followed by "Mati Therapeutics Inc." with 2 trials sponsored, "ICON Bioscience Inc" with 1 trials sponsored, "Ophthalmic Consultants of Long Island" with 1 trials sponsored and "Research Insight LLC" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Ophthalmic Consultants of Long Island" #1 collaborator was "Science in Vision" with 2 trials as a collaborator, "Abbott Medical Optics" with 1 trials as a collaborator and "Ocular Therapeutix, Inc." with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Ophthalmic Consultants of Long Island" are "Cataract" (3 trials), "Astigmatism Bilateral" (1 trials), "Cataract Bilateral" (1 trials), "Dry Eye Syndromes" (1 trials) and "Inflammation" (1 trials). Many other conditions were trialed in "Ophthalmic Consultants of Long Island" in a lesser frequency.

Most popular intervention types in "Ophthalmic Consultants of Long Island" are "Drug" (4 trials), "Device" (2 trials), "Combination Product" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Dexamethasone" (2 trials), "Dexycu intracameral dexamethasone" (1 trials), "Ilevro" (1 trials), "Moxifloxacin HCl 0.5%" (1 trials) and "NDE L68 StableFit® Punctal Plug" (1 trials). Other intervention names were less common.

The vast majority of trials in "Ophthalmic Consultants of Long Island" are 7 trials for "All" genders.

Currently, there are NaN active trials in "Ophthalmic Consultants of Long Island". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in Ophthalmic Consultants of Long Island, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Ophthalmic Consultants of Long Island, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 2 trials that are defined as “Not Applicable".